Clinical Trial Update: Neo-Adjuvant Study in Triple Negative Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 neo-adjuvant trial in triple-negative breast cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-08-10